3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Osteosarcoma
1
Neuroblastoma
1
Chickenpox
1
Interventions
Cyclophosphamide
14
Temozolomide
10
Magnetic Resonance Spectroscopy
10
dinutuximab
9
Biopsy
9
X-Rays
8
Specimen Handling
8
Irinotecan
8
Phantoms, Imaging
7
fludarabine
6
Topotecan
6
Nuclear Medicine Department, Hospital
6
Vincristine
5
3-Iodobenzylguanidine
5
sargramostim
4
fludarabine phosphate
4
Melphalan
4
Isotretinoin
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Etoposide
4
tipifarnib
3
Radiotherapy
3
Filgrastim
3
Doxorubicin
3
Colony-Stimulating Factors
3
Carboplatin
3
ulixertinib
2
tazemetostat
2
selpercatinib
2
saponin QA-21V1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Herpes Zoster Vaccine
×
90 days
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled